Big Pharma's hunting the generics.......................

Big pharma daddy's pipeline is drying up in the coming decades and beacuse of generic competion many large pharmaceuticals are loosing into their profit margins, so the stratergy both GSK and Pfizer are following is that they atr activeky hunting out for good profitable generic companies in the emerging market.

for sometime around GSK has been making headlines with many smaller and medium size generic and bio similar acquisition and now pfizer is rolling uo its sleeves and has started its stratergia acquisitions in the emerging markets such as Turkey in Middle east. Some reports have stated that Pfizer has announced that it wants to have generic drugs revenue to be more than 3 Biollion by year 2012.